Form D · Pharmaceuticals
PACGEN BIOPHARMACEUTICALS CORP
Vancouver, A1 · CIK 0001431970
Offering snapshot reported Apr 11, 2011 · SEC filing
- Reported sold
- $12.3K Offering amount: $12.3K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 31, 2011 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 11, 2011 | Initial | $12,288 | No comparison | 2 | SEC filing |
| Apr 7, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-158170
Source: Form D, filed Apr 11, 2011. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joel Cheng | Executive |
| Lewis Choi | Executive |
| John Hsuan | Director |
| Fred Huang | Director |
| Beverly Incledon | Executive |
| Telvin Ju | Director |
| Gabriel Lam | Executive |
| Yiu Chung Lee | Director, Executive |
| Kevin Mc Garry | Director |
| Alan Moore | Director |
| Chin Lin Tsong | Director |
| Chung Yu Wang | Director |
| Christina Yip | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
701 West Georgia Street Suite 1500
Vancouver, A1, V7Y 1C6
Vancouver, A1, V7Y 1C6